Severe vascular spasm due to erythromycin-ergotamine interaction

Area of Science:

• Pharmacology
• Toxicology
• Clinical Medicine

Background:

• Drug interactions can lead to unexpected and severe adverse events.
• Ergotamine tartrate is used for migraines but has a narrow therapeutic index.
• Erythromycin is a common antibiotic with known drug interaction potential.

Observation:

• A patient developed ergotism after receiving a low dose of ergotamine tartrate (2 mg).
• The ergotism was characterized by severe peripheral vasospasm and dysesthesia.
• Transient renal ischemia was also observed in the patient.

Findings:

• The interaction between erythromycin and ergotamine tartrate precipitated the ergotism.
• Recovery was spontaneous over several weeks.
• Sodium nitroprusside therapy was not required for recovery.

Implications:

• Highlights the critical importance of reviewing concomitant medications for potential interactions.
• Underscores the need for caution when prescribing erythromycin with drugs metabolized by CYP3A4, like ergotamine.
• Suggests that even low doses of ergotamine can cause toxicity in the context of interacting medications.